Effect of Monocyte Locomotion Inhibitory Factor (MLIF) on the Activation and Production of Intracellular Cytokine and Chemokine Receptors in Human T CD4+ Lymphocytes Measured by Flow Cytometry by Sara Rojas-Dotor
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Effect of Monocyte Locomotion Inhibitory  
Factor (MLIF) on the Activation and  
Production of Intracellular Cytokine and 
Chemokine Receptors in Human T CD4+ 
Lymphocytes Measured by Flow Cytometry 
Sara Rojas-Dotor 
Unidad de Investigación Médica en Inmunología, Instituto Mexicano del Seguro Social 
México 
1. Introduction 
The supernatant of Axenically cultured Enatamoeba histolytica (E. histolytica) produces a 
thermostable factor that was purified and characterized by high resolution chromatography 
(HPLC) and mass spectrometry (MS-MS), supplemented by the methods of Edman (Edman 
& Begg, 1967). This revealed a pentapeptide with a molecular weight of 583 Daltons and 
established the aminoacid sequence (Met - Gln - Cys - Asn - Ser), which was termed 
Monocyte Locomotion Inhibitory Factor (MLIF). MLIF has powerful and selective anti-
inflammatory properties, which were established in vitro by Boyden chamber studies. MLIF 
inhibits locomotion, both random chemokinetic and chemotactic, of mononuclear 
phagocytes (PM) from normal human peripheral blood but not of neutrophils toward 
various attractants, such as C5a-Desargues lymphokine and Lymphocyte-derived 
chemotatic factor (LDCF) (Kretschmer et al., 1985). This factor also depresses the respiratory 
burst of monocytes and neutrophils activated with zymosan in vitro, as measured by 
chemiluminescence (Rico et al., 1992), and nitric oxide production in mononuclear 
phagocytes and human polymorphonuclear neutrophils (PMNs) (Rico et al., 2003). Such 
effects were not accompanied by changes in expression of CD43, a ligand critical in the 
initial activity of phagocytes, in the membrane of these cells, and did not affect the viability 
of phagocytes (Kretschmer et al., 1985). In contrast, MLIF does not affect either locomotion 
or the respiratory burst of zymosan-activated human PMNs (Rico et al., 1998). In vivo, MLIF 
delays the arrival of mononuclear leukocytes in Rebuck chambers applied to the skin of 
healthy human volunteers (Kretschmer et al., 1985), inhibits cutaneous delayed contact 
hypersensitivity to 1-chloro-2-4-dinitrobenzene (DNCB) in guinea pigs (Giménez-Scherer et 
al., 1997) and decreases expression of the adhesion molecules VLA-4 on monocytes and 
VCAM-1 in the vascular epithelium (Giménez-Scherer et al., 2000). MILF inhibits the 
expression induced in inflammatory proteins such as MIP-1ǂ and MIP-1β in U-937 cells, 
which are NF-κB pathway-regulated proteins (Utrera-Barillas et al., 2003). The p65–p50 
heterodimer comprises the most abundant form of NF-κB in a PMA-induced system. 
Temporary studies showed that MLIF induces p50 translocation, which may be explained 
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by the ability of MLIF to induce AMPc synthesis and protein kinase A phosphorylation in 
NF-κB and IκB followed by NF-κB translocation (Kretschmer et al., 2004). This may also 
explain the atypical inflammation observed in invasive amoebiasis, in which there is 
decreased chemotaxis and disequilibrium in cytokine production. This is supported by in 
vivo observations that MLIF notably decreased cellular infiltration and inflammatory 
cytokine expression.  
 The selective actions of MLIF upon a variety of cell types suggest that it disrupts an 
organism's pro- and anti-inflammatory network (Giménez-Scherer et al., 1987; Kretschmer et 
al., 1985, 2001; Rojas-Dotor et al., 2006). A pentapeptide with the same amino acids but in a 
different sequence, termed a MLIF scramble (Gln-Cys-Met-Ser-Asn), showed no anti-
inflammatory properties (Giménez-Scherer et al., 2004). The observed effects of MLIF could 
be attributed to the chemical activity of the peptide. Ongoing studies in quantum chemistry 
have revealed that a pharmacophore group in the MLIF sequence, Cys-Asn-Ser, could be 
responsible for most of the anti-inflammatory properties of the molecule (Soriano-Correa et 
al., 2006) Figure 1.  
It is possible that MLIF is derived from a larger peptide or protein synthesized by the 
amoeba, which is then degraded by proteases present in the cytoplasm. The lysate of 
amoebae material, washed and processed according to the method of Aley (Aley et al., 
1980), maintains the inhibitory activity, suggesting that the MLIF is produced by the amoeba 
through de novo synthesis and not due to a complex-degradation process of ingestion and 
regurgitation of a product present in axenic medium (Rico et al., 1997).  
 
Fig. 1. Molecular Structure of Monocyte Locomotion Inhibitory Factor (Met-Gln-Cys-Asn-
Ser). The pharmacophore site, Cys-Asp-Ser, is highlighted (Soriano-Correa et al., 2006) 
MLIF seems to be exclusively produced by E histolytica and other related amebas, E. invadens 
and E. moshkovski, but it is absent in E. dispar, as we corroborated through the gene bank in 
which we only found the MLIF genetic sequence in the E histolytica, and not in any other 
parasites. Infections caused by E histolytica induce a transitory cell-mediated immunity-
suppressed state in early inflammatory stages in the amebic hepatic abscess (AHA), and a 
complex cytokine signaling system is activated due to invasion of the parasite (Chadee & 
Meerovitch, 1984). 
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Inflammation is the body’s reaction against invasion by an infectious agent, an antigenic 
stimulus or even just physical injury. This response induces the infiltration of leukocytes 
and plasma molecules into regions of infection or injury. Its main effects include increased 
blood flow to the region, increased vascular permeability allowing the passage of large 
serum molecules such as immunoglobulin and leukocyte migration through the vascular 
endothelium toward the inflamed area. Inflammation is controlled by cytokines, factors 
produced by mast cells, platelets and leukocytes, chemokines and plasma enzyme systems 
such complement, coagulation and fibrinolysis. Cytokines stimulate the expression of 
adhesion molecules by endothelial cells, and these adhesion molecules bind to leukocytes 
and initiate their attraction to areas of infection. Microbial products, such as peptides with 
N-formilmetionil, chemokines, and peptides derived from complement such as C5a, and 
leukotrienes (B4), act on leukocytes to stimulate their migration and their microbicidal 
abilities. The composition of cells involved in inflammatory processes changes with time 
and goes from neutrophil rich to mononuclear cell rich, reflecting a change in the leukocytes 
attracted (Roitt, 1998; Abbas & Lichtman, 2004). Macrophages attracted to the site of 
infection are activated by microbial products and interferon-gamma (IFN-γ) which cause 
them to phagocytose and kill microorganisms (Figure 2). 
 
Fig. 2. Cytokines play an important role in the development of acute or chronic 
inflammatory responses. Interleukin 1 (IL-1), IL-6, tumor necrosis factor alpha (TNF-α) and 
IL-12, in addition to cytokines and chemokines, have redundant and pleiotropic effects, 
which together contribute to the inflammatory response. If the antigen is eliminated, 
inflammatory cells become apoptotic or return to the circulation. If the antigen persists for 
several days, it will induce chronic inflammation, recruit mast cells, eosinophils, 
lymphocytes and macrophages, and induce the production of antibodies and cytokines. 
These cells are often found in damaged tissue. (Luscinskas & Gimbrone, 1996) 
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Chemokines are small polypeptides that activate and direct the migration of monocytes, 
neutrophils, eosinophils and activated T lymphocytes from the bloodstream to sites of 
infection. They also regulate pro-inflammatory signals by binding to specific receptors 
belonging to the superfamily of seven trans-membrane domain alpha protein-coupled G 
(such as trimeric guanosine triphosphate (GTP)), and these can also be used as markers to 
differentiate chemokines and their receptors can also be used as markers of differentiation of 
helper T cell populations, pro-inflammatory (Th1) or anti-inflammatory (Th2) (Mosmann & 
Fong, 1989). Th1 cells express on their cell surface CCR5 chemokine receptor but not CCR3, 
whereas Th2 cells express the chemokine receptor CCR3 but not CCR5 (Sallusto et al., 1998). 
It has been shown that several inflammatory chemokine receptors, such as CCR1, CCR2, 
CCR3, CCR5 and CXCR3, are expressed shortly after signaling through the T cell receptor 
(TCR) in Th1 and Th2 cells. In contrast to CCR7, CCR4 and CCR8, which are over-expressed 
after activation through the TCR, these changes in chemokine receptor expression can be 
used to modify the migratory behavior of activated Th cells, and to establish the hierarchy of 
action between the different chemokine receptors (Loetscher et al., 1998; Zingoni et al., 1998). 
2.1 Cytokines, soluble mediators 
Cytokines are small peptide proteins with hormone-like activity that play a central role in 
communication between cells of the immune system. They are soluble mediators and 
regulators of innate and specific immunity. Additionally, cytokines promote growth and 
differentiation of leukocytes and blood cell precursors. Cytokines are key mediators of 
inflammation in many diseases, such as rheumatoid arthritis, lupus erythematosus, asthma 
and allergies (Ruschpler & Stiehl, 2002; Ivashkiv, 2003, D'Ambrosio et al., 2002, 2003). The 
host defenses against infectious pathogens are highly cytokine-dependent mechanisms 
mediated by humoral or cellular immunity. Each mechanism preferentially acts against intra 
or extracellular pathogens, viruses or worms. These host defense responses are strictly 
regulated by cytokines secreted by T helper populations, Th1 and Th2 (Kawakami, 2002). 
Cytokines have autocrine activity, increasing the proliferation, differentiation and effector 
functions of their own cell subset, and may additionally have far ranging effects on other 
cell types. T helper lymphocytes, the main orchestrators of the immune response, are 
subdivided into T helper 1 (Th1) and T helper 2 (Th2) subsets by the range of cytokines they 
secrete. Th1 cells mainly secrete the cytokines that promote cellular immunity and the 
inflammatory process, such as Interleukin-2 (IL-2) and Interferon-gamma (IFN-γ). 
(Mosmann, 1997). In contrast, Th2 cells secrete IL-4, IL-5 and IL-10, which direct the immune 
response toward a more humoral (antibody-mediated) response and impair differentiation 
toward the Th1 phenotype (Figure 3). 
In the case of several infectious diseases, like-Leishmaniasis and HIV, the development of 
Th1-dependent immunity protects against the infectious agent. The development of Th2 
dependent immunity, in contrast, was determined to protect the parasite or virus. Down-
regulation of the immune response is a frequent parasitic strategy. Monitoring the immune 
response polarization toward a Th1- or Th2-type response is important for the development 
of effective vaccines. Because of the interplay between cytokines and the cells that respond 
to them, looking at changes in levels of soluble cytokines, changes in cell surface cytokine 
receptor expression and expression of intracellular cytokines by individual cell 
subpopulations is crucial to the understanding of cytokine biology. (Clark at al., 2011; 
Campanelli et al., 2010). 
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Fig. 3. Antigen-presenting cells (APCs) communicate with two types of helper T cells, Th1 
and Th2. They first produce cytokines, such as IFN-γ, TNF-α and IL-2, which are responsible 
for inflammation, and Th2 cells produce cytokines involved in the production of antibodies. 
The balance of activation of between Th1 and Th2, maintained by IFN-γ and IL-10, 
determines the nature of an immune response. Th17 cells are another recently identified 
subset of CD4+ T helper cells. They are found at the interfaces between the external 
environment and the internal environment, such as the in the skin and the lining of the 
gastrointestinal tract. Regulatory T cells respond to the presence of IL-2 by rapid 
proliferation. Because IL-2 is secreted by effector T cells, this provides a negative-feedback 
mechanism, in which inflammatory T-cell activity (e.g., by Th1 cells) is restrained by the 
resulting expansion of regulatory T cells (Image taken from www.imgenex.com) 
Lymphocyte activation, as measured early on by mitogenic assay, was used as an indicator 
of immune function. Mitogenic assays measure the proliferative response of isolated 
mononuclear cells to in vitro stimulation with mitogenic lectins (Phytohaemagglutinin, 
Concanalin A, and Pokeweed Mitogen) or certain specific antigens (Streptokinase, PPD). 
The proliferative index of activation is a proportion determined by the relative uptake of 
radiolabel nucleotides (3H-thimidine) by the mitogen-stimulated culture compared to a 
basal nonstimulated culture. Actively proliferating cells incorporate more radionucleotides 
than weakly proliferating cells. Non-proliferating cells should have little or no incorporation 
of radionucleotides. These assays are often 48-72 hours in length and require licensing, 
storage and disposal of radioactive waste. A similar flow cytometry-based assay utilizes the 
uptake of the non-radioactve nucleotide bromo-deoxyuridine (BrdU) and detection with a 
fluorescent anti-BrdU antibody. These assays are somewhat non-specific and provide little 
information regarding cytokine production or cell communication. These tests have recently 
been supplanted with flow cytometry-basad assays for measuring changes in cells surface 
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markers and assays for measuring the expression of intracellular cytokine. Flow cytometers 
are laser-based cell counters that are capable of distinguishing 3, 4, 5 or more (depending of 
flow cytometer), different fluorescence emissions, each associated with a particle identified 
by its light scatter proprieties. Fluorescence dyes with distinct fluorescence emissions are 
attached to monoclonal antibody that recognizes distinct cell surface antigens. 
Traditionally, cytokines have been measured by radioimmunoassay (RIA) and enzyme-
linked immunosorbent assay (ELISA). Unfortunately, these techniques are limited by their 
detection range and an inability to simultaneously measure multiple analytes (García, 1999).  
Using extremely sensitive multiparameter flow cytometers, Multiplexed Cytokine 
Immunoassay Kits overcome both of these limitations. Multiplexing is the simultaneous 
assay of many analytes in a single sample. Applications for flow cytometry are diverse, 
ranging from simple cell counting and viability to more complex studies of immune 
function, apoptosis and cancer, stem cells, separation of cells populations such as monocytes 
and T and B lymphocytes, measuring changes in cell surface markers, cell cycle analysis, 
cellular activation, and measuring the expression of intracellular cytokines (Collins et al., 
1998; McHugh, 1994; Spagnoli,et al., 1993; Trask et al., 1982). 
3. Cell activation 
Activation of lymphocytes is a complex yet finely regulated cascade of events that results in 
the expression of cytokine receptors, the production and secretion of cytokines and the 
expression of several cell surface molecules, eventually leading to divergent immune 
responses. Parasite-specific immune responses are regulated by cytokines and chemokines. 
They modulate and direct the immune response, but may also contribute to an infection 
induced by the pathogenesis and parasite persistence (Talvani et al., 2004). Parasitic 
infections frequently result in highly polarized CD4+ T cell responses, characterized by Th1 
or Th2 cytokine dominated production profiles. Although it was previously thought that 
these infections were strictly dependent on signaling by cytokines, such as IFN-γ, IL-12 and 
IL-4, recent data indicate that this polarization may be primarily directed by a series of 
different factors intrinsic to the pathogen–antigen-presenting-cell interaction that directs T 
cell priming, and that all of this is influenced by the local environment (Katzman et al., 
2008). The infection caused by the E. histolytica parasite is associated with an acute 
inflammatory response (Chadee & Meerovitch, 1984). However, it is not completely clear 
how E. histolytica triggers the host inflammatory response or how host-parasite interactions 
start, modulate, and eventually turn off the inflammatory response. 
During inflammation, leukocytes are orchestrated and regulated by the mononuclear 
leukocyte Thl/Th2 derived cytokine network. Thus, it was interesting for us to evaluate the 
effects of MLIF on lymphocyte activation and Thl/Th2 cytokine production. Additionally, it 
has been suggested that E. histolytica invasion occurs within a territory where the Thl 
response can be inhibited, this is, in an unbalanced environment where Thl < Th2. In this 
experiment, we evaluated the in vitro effect of MLIF on the activation and production of 
Thl/Th2 intracellular cytokines (IL-1β, IL-2, INF-γ IL-4, and IL-10) and the relation with the 
chemokine receptors CCR4 and CCR5 in human CD4+ T cells. Peripheral blood samples 
were obtained from healthy, nonsmoking adult volunteer donors of both sexes. The 
peripheral blood mononuclear cells were obtained by Ficoll-Hypaque (Sigma Chemical Co., 
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Louis, MO) and CD4+ T lymphocytes were obtained by negative selection technique 
(MACS® Reagents, Kit isolation, Human cell T CD4+). The purity of lymphocytes was 
analyzed by flow cytometry. The flow cytometry measures and analyzes the optical 
properties of individual cells pass through a laser beam. Depending on how cells interact 
with the laser beam, the cytometer measures five parameters for each cell: size (forward 
scatter, FSC), complexity (side scatter, SSC) and three fluorescence emissions (FL-1, FL-2 and 
FL -3). An electro-optical system converts the voltage signals, which is translated into a 
digital value which is stored in a computer, the data are then retrieved and analyzed with 
the software that combines information from different cells in statistical charts, which 
measure individual parameters (histograms) or two parameters at a time (dot plot, density 
or contour). For our study, purified lymphocytes were analyzed in a dot plot of SSC vs. FSC 
marking the region corresponding to lymphocytes, excluding debris and dead cells. In a dot 
plot is compensated for fluorescence with anti CD3-FITC and anti-CD4-PE (cluster of 
differentiation (CD) and marker for T lymphocytes CD4+). 
Test samples of at least 10.000 events were acquired under these conditions. With this 
procedure, we obtained a population of CD4+ lymphocytes with 96% purity. (Figure 4) 
 
Fig. 4. Simple analysis of CD4+ T cells obtained from healthy individuals by flow cytometry. 
The X-axis shows staining with fluorescein isothiocyanate (FITC), and the Y-axis shows 
staining for phycoerythrin (PE). a) Autofluorescence; b) Isotype control, staining with mouse 
IgG1-FITC; c) Staining for subpopulations of CD3 coupled to FITC; d) Staining for 
subpopulations of CD4 coupled to PE. All stains show simple representation of the 
histogram and are an example of 6 experiments ± SE 
The presence or absence of chemokine receptors on cell surfaces also provides information 
regarding the cell’s state of activation. Chemokine receptors can by analyzed by flow 
cytometry using fluorescently labeled anti-receptor antibodies or fluorescently-labeled 
chemokines. Combining these reagents with antibodies against the activation marker CD69 
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enables analysis of cell activation within specific cell population. Figure 5 shows that the 
best activation was obtained with 50 ng of phorbol 12-myristate 13-acetate (PMA) and 50 μg 
of MLIF. 
CD69 is a cell surface activation marker expressed on T cells, B cells, and activated NK cells. 
MLIF is able to induce expression of this marker, suggesting that it activates CD4+  
T lymphocytes. T-lymphocyte activation is also associated with an up-regulation of cell 
surface chemokine receptors. (Figure 5) 
 
Fig. 5. Expression of the chemokine receptor CXCR3 and the activation marker CD69  
Cell surface expression of the chemokine receptor CXCR3 and the activation marker CD69 
on CD4+ T cells after 24 hours of treatment with RPMI medium alone or activation with 
PMA and MLIF at different concentrations. The cell population positive for both CXCR3 and 
CD69 were identified using a FITC-labeled anti-CD69. 
4. Cell surface molecules  
Cellular activation may modify the expression of chemokines and chemokine receptors, 
which are essential for leukocyte recruitment during inflammation. Once activated,  
T lymphocytes acquire different migratory capacities and are necessary for efficient immune 
response regulation (Mackay, 1993; Katakai et al., 2002). CCR5 is a receptor that regulates 
normal activation, and it was expressed along with the tested Th1 cytokines. However, 
MLIF exposure inhibited these cells and induced significant decreases in production of IFN-
γ and IL-1ǃ. IFN-γ exerted a strong influence on Th1/Th2 polarization, and also affected 
chemokine receptor expression. MLIF induced an increase in CCR5 and CCR4 expression; 
however, this increase was only significant for the first. The observed CCR5 increase was 
greater in CCR4+ cells than in CCR4- cells (31% vs. 7%). The increases in CCR5 expression 
cannot be considered as a pro-Th1 response. The chemokine receptors, which are key factors 
in immune regulation, are influenced by MLIF. Th2 cells exhibited high CCR4 expression 
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levels in response to MLIF and, when co-expressed, the increase was even greater, 
demonstrating that MLIF possessed an additive effect on these markers (Figure 6) (Rojas-
Dotor et al., 2009). 
 
Fig. 6. Expression profiles of CCR4, CCR5, and CCR4/CCR5 on isolated CD4+ T cells. 5 × 105 
CD4+ T lymphocytes were cultured for 24 h with RPMI or MLIF (50 μg/mL). Cells were 
stained with PE or FITC anti- human CCR4, anti-human CCR5, or anti-human CCR4/CCR5 
mAbs. Box plots represent range, 25th and 75th percentiles, and vertical lines represent the 
10th and 90th percentiles of data. Horizontal bars show significant statistical differences 
among the different groups. NS = no significant difference. Values (p) were calculated using 
a Mann-Whitney Test. Dot plots show the co-expression of CCR4/CCR5, and bold numbers 
are the mean of three independent experiments 
5. Intracellular cytokines 
The effect of MLIF upon the production of intracellular cytokines was evaluated using a 
quantitative method of flow cytometry. This was used to assess the production of IL-lβ, IL-2, 
IFN-γ, IL-4, and IL-10. CD4+ T cells were cultured in 24-well plates in RPMI-1640 medium 
(supplemented with fetal calf serum (FCS), L-glutamine, streptomycin, gentamicin, and 
sodium pyruvate) with PMA alone or in conjunction with MLIF for 24 h at 37 ºC with 5% 
CO2. Cell viability was ≥ 90% determined by trypan blue dye (Sigma) exclusion. Once CD4+ 
T lymphocytes were activated, we determined if the effect of MLIF on cytokine production 
was related to a Th1 or Th2 cytokine pattern. To stain for intracellular cytokine expression, 
lymphocytes are labeled with anti-CD antibodies to identify cells by their subset, such as 
helper lymphocytes, B lymphocytes and cytotoxic lymphocytes. The cells are then stabilized 
by fixation with formaldehyde. Holes are punched in the cell membrane by detergent to 
enable the passage of anti-cytokine antibodies to the interior of the cells. By three-color flow 
cytometry analysis, activated T- lymphocytes can be subdivided into several different 
populations according to their staining characteristics. CD4 and CD3 positive and negative 
cells populations are identified using a FITC or PE-labeled anti-CD4 or CD3 antibody, which 
labels the cell surface. Following the permeabilization step, intracellular cytokines are 
stained with anti-human mAbs directed against IL-1β, IL-2, IFN-γ, IL-4, and IL-10, and Th1 
and Th2-associated cytokine-producing lymphocytes can be counted on a flow cytometer. 
This procedure helps to differentiate between Th1 (IFN-γ producing) and Th2 (IL-4 producing) 
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cells in specific cell populations. MLIF increased the expression of IL-lβ, IL-2, IFN-γ, IL-4, 
and IL-10. Following PMA+MLIF treatment, the production of IFN-γ and IL-1β was 
inhibited compared to treatment with PMA alone. MLIF possessed the ability to 
nonspecifically activate CD4+ T cells, and it induced an increase in pro- and anti-
inflammatory cytokine production (IL-1β, IL-2, IFN-γ, IL-4, and IL-10) (Rojas-Dotor et al., 
2006). In contrast, in PMA +MLIF-incubated cells, we found that IFN-γ and IL-1β production 
was inhibited and production of IL-10, the prototypical anti-inflammatory cytokine, was 
increased (Figure 7) (Rojas-Dotor et al., 2009). It is probable that MILF induces a signaling 
cascade, which results in the activation of transcription factors, such as nuclear factor kB 
(NF-kB) (Kretschmer et al., 2004). After its translocation into the nucleus, NF-kB binds to 
genomic sites that regulate a large number of genes implicated in cytokine production. In 
this way, E. histolytica could potentially first establish an acute transitory reaction involving 
pro-inflammatory cytokines, followed by an increase and dominant pattern of anti-
inflammatory signals mainly through increased IL-10. IL-10 could cause the decreased 
inflammatory reaction observed in the advanced states of invasive amoebiasis (Kretschmer 
et al., 1985).  
 
Fig. 7. Intracellular cytokine production 
5 × 105 CD4+ T lymphocytes were cultured for 24 h in the presence of RPMI, MLIF, PMA, or 
PMA+MLIF. Brefeldin A, a cellular transport inhibitor was added during the last 6 h of 
culture . Cells were permeabilized and stained with anti-human cytokine mAbs (IL-1β, IL-2, 
IFNγ, IL-4, and IL-10) or mouse anti-IgG as an isotype control. FACScan dot plots are 
representative of control and treated cells. The numbers in each quadrant indicate the mean 
of the 6 independent experiments. In A, B, C, D, and E, the histograms represent control 
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(white), MLIF (diagonals), PMA (dotted), and PMAM+ MLIF (black) treated cells and 
untreated cells represent mean values ± SEM. Asterisk shows comparison among groups,  
*p <0.05 (Mann-Whitney Test). Bold numbers (dot plots) represent the mean. 
6. Cytokines and chemokine receptors 
The presence and regulation of cytokines and chemokines receptors were studied with 
MLIF. The cells were also stained to detect chemokine receptors and cytokine with the 
following combinations of mAb: anti-IL-1βPE/anti-CCR5FITC, anti-IL2FITC/anti-CCR5PE, 
anti-IFNγ PE/anti-CCR5FITC, anti-IL-4PE/anti-CCR4FITC and anti-IL-10FITC/anti-CCR4PE 
(PharMingen). 5 X105 CD4+ T cells from each group were incubated in 24-well plates for  
24 h; 10 μg/ml brefeldin A were added and incubated for the last 6 hours. After incubation, 
cells were centrifuged for 5 min at 400g and supernatants were aspirated without disturbing 
pellets. Cells were washed with PBS/0.5% albumin/2mM EDTA then they were marked 
with mAb, and incubated for 20 min at 4°C in the dark, and fixed with 1% p-formaldehyde 
according to the manufacturer’s instructions (PharMingen). Acquisition of 10,000 events was 
conducted in flow cytometry FACScan (BD Biosciences, Sa Jose, USA). For analysis, Facs 
Diva and Win MDI 2.8 software were used. The results showed that CD4+ T cells control 2% 
co-expressed IL-lβ/CCR5, IL-2/CCR5, and IFN-γ/CCR5, while 3% co-expressed  
IL-4/CCR4, and 1% co-expressed IL-10/CCR4. After stimulating CD4+ T cells with MLIF, 
15% cells co-expressed IL-1β/CCR5, 21% IL-2/CCR5, and 16% IFN-γ/CCR5, while 18%  
co-expressed IL-4/CCR4 and 16% IL-10/CCR4. PMA increased the expression of all of them 
(24%, 28%, 23%, 32%, and 31% respectively) and the combination PMA+MLIF showed that 
MLIF inhibited significant IL-1β/CCR5 (p<0.05) and IFN-γ/CCR5 (p< 0.002) induced by 
PMA (figure 8). 
 
Fig. 8. Cytokine and chemokine receptor co-expression 
www.intechopen.com
 
Clinical Flow Cytometry – Emerging Applications 
 
12 
Cells were cultured with RPMI, MLIF, PMA, or PMA+MLIF for 24 h at the previously 
mentioned concentrations. Brefeldin A was added during the last 6 h of culture. The cells 
were first stained to detect the surface cell molecules with anti- human CCR5 or CCR4 
mAbs. They were then permeabilized and stained with mAbs directed against IL-1β and 
CCR5, IL-2 and CCR5, IFNγ and CCR5, IL-4 and CCR4, or IL-10 and CCR4 and were 
analyzed on a flow cytometer. A, B, C, D, and E. FACScan dot plots are representative 
staining of the control and the treated cells, bold numbers represent the mean of the 6 
additional experiments. The histograms represent control (white), MLIF (diagonals), PMA 
(dotted), and PMAM+ MLIF (black) treated cells and untreated cells represent mean values 
± SEM. Asterisks indicate significant differences between the groups, *p <0.05, **p<0.002 
(Mann-Whitney Test).  
The precise mechanisms through which MLIF causes these biological effects are unknown, 
but it is known that MLIF interacts with human leukocytes by means of a mannose-
containing receptor (Kretschmer et al., 1991), and that it causes an increase in the number of 
pericentriolar microtubules and cytoplasmic AMPc concentration without concomitant 
GMPc diminution (Rico et al., 1995). Recent studies show that the MLIF does not interfere 
with programmed cell death or necrosis (Rojas-Dotor et al., 2011). 
 Given the level of activity of the studied cytokines, we observed that MLIF acted to 
promote cell populations that express IL-2/IL-10 or IFN-γ/IL-10 and CCR4/CCR5 
chemokine receptor. These effects have been previously reported and are associated with 
pro- and anti-inflammatory functions (Katsikis et al., 1995). In previous work, MLIF was 
found to inhibit the induction of CC, MIP-1α, MIP-1β, and I-309 chemokines, the CCR1 
receptor (Utrera-Barrillas et al., 2003), and the IL-1β, IL-5, and IL-6 cytokines (Rojas-Dotor et 
al., 2006). This behavior may be associated with the atypical inflammation observed in 
invasive amoebiasis in which there is a decrease in chemotaxis and disequilibrium in 
cytokine production. This conclusion is supported by observations in vivo in which MLIF 
notably decreased cellular infiltration and inflammatory cytokine expression.  
7. Conclusion 
Entamoeba histolytica produces Monocyte Locomotion Inhibitory Factor (MLIF), a 
pentapeptide with proven anti-inflammatory properties both in vitro and in vivo. MLIF may 
contribute to the exiguous inflammation observed in late amebic liver abscess, through 
effects exerted directly on monocytes, such as decreased locomotion and respiratory burst, 
or indirectly by modulating the production and expression of cytokines involved in 
mononuclear cell recruitment to the inflammatory focus. We evaluated the effect of MLIF on 
the expression of pro and anti-inflammatory CD4+ T cells after 24 h of incubation with 
RPMI, MLIF, PMA or PMA + MLIF. MLIF treatment increased expression of CD69 by these 
cells, from which we can infer that MLIF acts as an inducer or activator of CD4+ cells under 
these experimental conditions. The expression of the cytokines IL-1β, IFN-γ, IL-2, IL-4 and 
IL-10 and co-localization with the chemokine receptors IL-1 β/CCR5, IFN-γ/CCR5,  
IL-2/CCR5, IL-4/CCR4 and IL-10/CCR4 are induced by MLIF. While PMA-induced 
production of IL-1 ǃ and IFN- γ was inhibited by MLIF, IL-2 production was not affected, in 
contrast to the expression of IL-10, which was increased by MLIF. The inhibitory effect of 
MLIF could be explained by two different and independent mechanisms: inhibition of pro-
inflammatory cytokines such as IL-1 ǃ and IFN-γ or increased expression of IL-10, with the 
concomitant increase in the suppressive effects attributed to IL-10. 
www.intechopen.com
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MLIF acts at the beginning of the inflammatory process as a nonspecific activator, inducing 
the production of both pro and anti-inflammatory cytokines. As inflammation progresses, 
Th2 cytokine production prevails, which may inhibit Th1 cytokines. The observed effect of 
MLIF in this study could be explained by Th1 inhibition, as decreases in IFN-γ, IL-1ǃ, 
cytokine and IL-1ǃ/CCR5, IFN-γ/CCR5 cytokine and chemokine receptor co-expression 
were observed along with increases in the Th2 factors IL-4/CCR4 and IL-10/CCR4, 
resulting in a predominantly anti-inflammatory Th1<Th2 pattern.   
The effects of MLIF on the expression of cell surface molecules and intracellular cytokine 
expression was made possible by the availability of a range of monoclonal anti- antibodies 
coupled to fluorochromes, such as FITC or PE, and analysis by flow cytometry. 
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